Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1479 of 6351
-
Could a headset at home boost brain recovery? new study tests tDCS for stroke, tumors, and neurodegeneration
Symptom relief OngoingThe purpose of this study is to assess the feasibility of home-based Transcranial Direct Current Stimulation (tDCS) combined with a home activity based therapy program in patients with stroke, brain tumors or neurodegenerative conditions and to assess the efficacy of home-based t…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New drug combo may keep severe colitis patients out of the hospital
Disease control Recruiting nowThis trial is being conducted to learn more about the optimal sequence of various medications in the management of acute severe ulcerative colitis (ASUC). This research is studying multiple drugs already approved by the Food and Drug Administration (FDA). The goal of this study …
Phase 4 • Sponsor: Berinstein, Jeffrey • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New pill could ease psoriatic arthritis pain in 12 weeks
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with active psoriatic arthritis. A total of 222 subjects are planned to be included.
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Which biologic best stops Crohn's from coming back after surgery?
Disease control Recruiting nowThis retrospective cohort study aims to compare the efficacy of different biologics in preventing postoperative endoscopic recurrence in Crohn's disease (CD). It plans to include 198 adult patients who underwent bowel resection and initiated prophylactic biologic therapy between …
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug duo aims to fight Hard-to-Treat cancers
Disease control Recruiting nowThis open-label, dose-finding, and proof of concept study will evaluate the safety, tolerability, maximum-tolerated dose (MTD) and/or optimal dose of nenocorilant when administered in combination with nivolumab in patients with advanced solid malignancies.
Phase 1/2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New pill could help ITP patients who failed standard treatments
Disease control Recruiting nowThis is a Phase 2, open-label, randomized, multicenter study to assess the efficacy and safety of DZD8586 in patients with primary immune thrombocytopenia (ITP). The target population of this study is patients with primary ITP who had failed to respond or relapsed after receiving…
Phase 2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo therapy aims to stop lung cancer's return after surgery
Disease control Recruiting nowThis study will be conducted at Fujian Provincial Cancer Hospital. Its main goals are to evaluate the progression-free survival (PFS) and safety of postoperative immunotherapy combined with radiotherapy in patients with high-risk stage Ⅲ N2 non-small cell lung cancer after surger…
Phase 4 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New psoriatic arthritis drug shows promise in Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA). The study aims to see whether treatment with JNJ-88545223 can help reduce the signs and symptoms of…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can acupuncture boost lung cancer treatment? new trial aims to find out
Disease control Recruiting nowThis multicentre, randomized controlled trial evaluates the effect and safety of acupuncture combing with PD-1 inhibitors plus chemotherapy in NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four-six cycl…
Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Exercise may ease MS pain without drugs
Symptom relief Recruiting nowThe primary goal of this study is to test whether 12 weeks of progressive resistance exercise is an effective non-pharmacological treatment for reducing pain in people with multiple sclerosis and chronic pain. The study will be a randomized controlled trial with multiple trainin…
Sponsor: University of Aarhus • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New RSV shot for babies enters early human trials
Prevention Not yet recruitingThis trial employs a randomized, double-blind, placebo/positive control, and dose-finding design to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary efficacy of SIBP-A16 injection in premature and term infants.
Phase 1/2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
New heart drug tested in real-world chinese patients
Disease control Recruiting nowThe purpose of this study is to assess the effectiveness of mavacamten treatment in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) in real-world clinical practice
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New Dual-Target PET probe aims to sharpen cancer detection
Diagnosis Not yet recruitingMalignant tumors pose a grave threat to human health and impose a substantial burden on society. Molecular imaging, which enables non-invasive, in vivo visualization of biological processes at the molecular level, is crucial for early diagnosis and treatment monitoring, thereby i…
Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Could a diabetes pill also calm psoriasis? new study aims to find out
Disease control Recruiting nowThis study will evaluate the effects of oral semaglutide in combination with topical corticosteroid/calcipotriol on clinical outcomes and metabolic inflammation in patients with plaque psoriasis and overweight/obesity and/or type 2 diabetes mellitus. A total of 62 participants wi…
Phase 4 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Light therapy offers hope for cancer survivors with chronic swelling
Symptom relief Recruiting nowThe U.S. Food and Drug Administration approved photobiomodulation therapy (PBMT) as a treatment for breast cancer-related arm lymphedema (BCRL) in 2006. The investigators conducted two pilot clinical trials. Results demonstrated the feasibility, acceptability, and preliminary eff…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Brain pacemaker targets cerebellum to quiet severe tremors
Disease control Recruiting nowThis objective of this study is to document the safety and feasibility of electrical stimulation of the deep cerebellar nuclei for refractory tremor using the Medtronic Percept RC Deep Brain Stimulation System. The population will consist of patients that have either failed a pri…
Phase 1 • Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a simple liver scan replace risky heart catheters?
Diagnosis Not yet recruitingThis is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certa…
Sponsor: Echosens • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC
-
Could less radiation be safer? new trial aims to cut side effects after head and neck cancer surgery
Disease control Recruiting nowCOMPORT is a multicenter phase II clinical trial evaluating a personalized approach to postoperative radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC). The study investigates whether a risk-adapted, compartmentalized radiotherapy strategy can safely redu…
Phase 2 • Sponsor: Olgun Elicin • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Ultrasound-Guided Beta-Blockers: a new hope for septic shock?
Disease control Not yet recruitingThe goal of this pilot clinical trial is to determine if conducting a larger study using point-of-care ultrasound (POCUS) to guide beta-blocker therapy in patients with septic shock is feasible. Septic shock is a life-threatening condition where infection causes dangerously low b…
Phase 1/2 • Sponsor: John Basmaji • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Ketamine may offer new hope for phantom limb pain sufferers
Symptom relief Recruiting nowMust be living Within a 50 mile radius of our study sites: Bay Area, Los Angeles, Albuquerque, Sacramento, Los Angeles An anecdotal report with administration of ketamine in a non-clinical setting providing and sustained remission of symptoms after 6 years has furthered the inte…
Phase 2/3 • Sponsor: The Ketamine Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC